| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PEBP1 |
PEBP1, PBP, PEBP: Phosphatidylethanolamine-binding protein 1 |
3.262 |
Evidence |
O
|
| BIRC5 |
BIRC5, API4, IAP4: Baculoviral IAP repeat-containing protein 5 |
CCNB2 |
CCNB2: G2/mitotic-specific cyclin-B2 |
3.26 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
SLC22A7 |
SLC22A7, RP11-480N24.7-001, hCG_19011: Solute carrier family 22 |
3.26 |
Evidence |
|
| CETN2 |
CETN2, CALT, CEN2: Centrin-2 |
PRKX |
PRKX, PKX1: Serine/threonine-protein kinase PRKX |
3.25 |
Evidence |
|
| HIST1H4A |
HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H |
HIST1H2AC |
HIST1H2AC, H2AFL: Histone H2A type 1-C |
3.25 |
Evidence |
|
| CCNB2 |
CCNB2: G2/mitotic-specific cyclin-B2 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
3.25 |
Evidence |
|
| H2AFZ |
H2AFZ, H2AZ: Histone H2A.Z |
HIST2H2BE |
HIST2H2BE, H2BFQ: Histone H2B type 2-E |
3.25 |
Evidence |
|
| TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
HIST2H2BE |
HIST2H2BE, H2BFQ: Histone H2B type 2-E |
3.25 |
Evidence |
|
| CCNC |
CCNC: Cyclin-C |
PRKAA2 |
PRKAA2, AMPK, AMPK2: 5'-AMP-activated protein kinase catalytic subunit alpha-2 |
3.25 |
Evidence |
|
| JAM2 |
JAM2, C21orf43, UNQ219/PRO245, VEJAM: Junctional adhesion molecule B precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
3.25 |
Evidence |
|
| HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
3.245 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
CHN2 |
CHN2, ARHGAP3, BCH: Beta-chimaerin |
3.245 |
Evidence |
|
| CRKL |
CRKL: Crk-like protein |
SHB |
SHB: SH2 domain-containing adapter protein B |
3.245 |
Evidence |
|
| SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
VAV3 |
VAV3: Protein vav-3 |
3.245 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
3.245 |
Evidence |
|
| SASH1 |
SASH1, KIAA0790, PEPE1: SAM and SH3 domain-containing protein 1 |
GRAP |
GRAP: GRB2-related adapter protein |
3.237 |
Evidence |
|
| HSPA9B |
HSPA9, GRP75, HSPA9B: Stress-70 protein, mitochondrial precursor |
EIF3S10 |
EIF3S10, KIAA0139: Eukaryotic translation initiation factor 3 subunit 10 |
3.23 |
Evidence |
|
| WDR12 |
WDR12: WD repeat-containing protein 12 |
DDX54 |
DDX54: ATP-dependent RNA helicase DDX54 |
3.222 |
Evidence |
O
|
| MYH10 |
MYH10: Myosin-10 |
ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
3.215 |
Evidence |
|
| MSI1 |
MSI1: RNA-binding protein Musashi homolog 1 |
TNPO1 |
|
3.215 |
Evidence |
|
| MYH10 |
MYH10: Myosin-10 |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
3.215 |
Evidence |
|
| PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
LCP1 |
LCP1, PLS2: Plastin-2 |
3.212 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
SHB |
SHB: SH2 domain-containing adapter protein B |
3.21 |
Evidence |
|
| PSMA7 |
PSMA7: Proteasome subunit alpha type-7 |
EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
3.21 |
Evidence |
|
| EFNA2 |
EFNA2, EPLG6, LERK6: Ephrin-A2 precursor |
ADAM17 |
ADAM17, CSVP, TACE: ADAM 17 precursor |
3.21 |
Evidence |
|
-